In addition to inducing fatty liver, HFD also promotes systemic metabolic syndrome with insulin resistance and glucose intolerance
Unusually for a peptide it is stable in gastric acid, which is why it has been studied across both systemic and gastrointestinal injury models
Thus, the heterozygous KEAP1 mutation conferring the growth advantage on cancers is consistent with the two-site binding model and hinge and latch model of the Keap1Nrf2 system
It supports angiogenesis, the blood vessel formation that supplies healing tissues
Currently, a lot has been done to uncover the pathways that govern the interactome between the hypothalamus and the liver [4,5,6]: (a) Electrical stimulation and surgical denervation approaches, alongside pharmacological inhibition of the autonomic nerves, evidenced the relevance of these neuronal connections in driving hepatic metabolic functions [4]